Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

PHARMACARE records net income of $3.41 million at the end of 2016

2017-02-19

According to the parent company data of Dar Al-Shifa Pharmaceuticals Company PHARMACARE for the year-end 2016, net profit after tax reached 3,414,672 USD, compared with a net profit after tax of 1,849,164 USD in the audited data for 2015, a net increase of 84.7%. Total assets of the company reached 51,137,343 USD as of December 31st, 2016, compared to total assets of 45,615,682 USD as of December 31st, 2015, a net increase of 12.1%. Total liabilities of the company reached 23,792,491 USD as of December 31st, 2016, compared to total liabilities of 21,072,784 USD as of December 31st, 2015, a net increase of 12.9%. Net ownership equity of the company reached 27,344,853 USD as of December 31st, 2016, compared with a net ownership equity of 24,542,898 USD as of December 31st, 2015, a net increase of 11.4%.


 

2021-04-08
QUDS approves distributing 3.50% stocks dividends and 4.50% cash dividends for the year 2020

2021-04-08
TRUST approves distributing 10% cash dividends for the year 2020

2021-04-08
Relative Calmness in the PEX and a momentum in holding the general assembly meetings

2021-04-08
NCI proposes distributing 10% cash dividends for the year 2020

2021-04-08
PEC approves distributing 10% cash dividends for the year 2020

2021-04-04
NIC approves distributing 15% stocks dividends and 22.5% cash dividends for the year 2020

2021-04-01
APIC proposes distributing 9.1476% stocks dividends and 7.50% cash dividends for the year 2020

2021-04-01
Al-Quds Index declines significantly following the dividends’ entitlement of the PEX’s two largest companies

2021-04-01
BOP approves distributing 1% stocks dividends and 4% cash dividends for the year 2020

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013